Detalhe da pesquisa
1.
Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025).
Antimicrob Agents Chemother
; 64(7)2020 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32376613
2.
MK-571, a Cysteinyl Leukotriene Receptor 1 Antagonist, Inhibits Hepatitis C Virus Replication.
Antimicrob Agents Chemother
; 64(6)2020 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32179525
3.
Small-Molecule Inhibitors of Cyclophilins Block Opening of the Mitochondrial Permeability Transition Pore and Protect Mice From Hepatic Ischemia/Reperfusion Injury.
Gastroenterology
; 157(5): 1368-1382, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31336123
4.
Characterization of the Anti-Hepatitis C Virus Activity of New Nonpeptidic Small-Molecule Cyclophilin Inhibitors with the Potential for Broad Anti-Flaviviridae Activity.
Antimicrob Agents Chemother
; 62(7)2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29760125
5.
Inhibition of RNA binding to hepatitis C virus RNA-dependent RNA polymerase: a new mechanism for antiviral intervention.
Nucleic Acids Res
; 42(14): 9399-409, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25053847
6.
Third Early "Booster" Dose Strategy in France of bnt162b2 SARS-CoV-2 Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients Enhances Neutralizing Antibody Responses.
Viruses
; 14(9)2022 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36146735
7.
Desloratadine, an FDA-approved cationic amphiphilic drug, inhibits SARS-CoV-2 infection in cell culture and primary human nasal epithelial cells by blocking viral entry.
Sci Rep
; 12(1): 21053, 2022 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36473907
8.
Proviral role of human respiratory epithelial cell-derived small extracellular vesicles in SARS-CoV-2 infection.
J Extracell Vesicles
; 11(10): e12269, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36271885
9.
Silibinin and related compounds are direct inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
Gastroenterology
; 138(3): 1112-22, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19962982
10.
Complex dynamics of hepatitis B virus resistance to adefovir.
Hepatology
; 49(1): 50-9, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19065672
11.
Fitness-associated substitutions following failure of direct-acting antivirals assessed by deep sequencing of full-length hepatitis C virus genomes.
Aliment Pharmacol Ther
; 52(10): 1583-1591, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32886807
12.
New pseudodimeric aurones as palm pocket inhibitors of Hepatitis C virus RNA-dependent RNA polymerase.
Eur J Med Chem
; 115: 217-29, 2016 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27017550
13.
Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities.
Nat Commun
; 7: 12777, 2016 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27652979
14.
B-ring modified aurones as promising allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
Eur J Med Chem
; 80: 579-92, 2014 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24835816
15.
Discovery of naturally occurring aurones that are potent allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
J Med Chem
; 54(15): 5395-402, 2011 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-21699179
16.
Hepatitis C virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice.
PLoS One
; 4(12): e8209, 2009 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-19997618
17.
Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real-time polymerase chain reaction-based method.
Hepatology
; 46(1): 22-31, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17525931
18.
The nonstructural 5A protein of hepatitis C virus genotype 1b does not contain an interferon sensitivity-determining region.
J Infect Dis
; 195(3): 432-41, 2007 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17205483
19.
Analysis of ribavirin mutagenicity in human hepatitis C virus infection.
J Virol
; 81(14): 7732-41, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17494069
20.
Efficacy and safety of adefovir dipivoxil 20 mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10 mg daily.
J Hepatol
; 46(5): 791-6, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17321635